STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Report
- Report Number
- 3009784280-2019-00530
- Event Type
- Injury
- Date Received
- July 18, 2019
- Date of Event
- January 9, 2019
- Report Date
- July 1, 2019
- Manufacturer
- SPECTRANETICS
- Product Code
- ONU
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
EVENT: CORRECTED APPROXIMATE MONTHS FROM 11 MONTHS TO 13 MONTHS.
APPROXIMATELY 13 MONTHS POST INDEX PROCEDURE, THE PATIENT EXPERIENCED RESTENOSIS.
THE PATIENT REQUIRED REVASCULARIZATION OF THE TARGET LESION. THIS IS BEING REPORTED AS A FOLLOW-UP TO THE CLINICAL STUDY. CROSS REFERENCE MFR REPORT NUMBERS: 3009784280-2019-00529, 3009784280-2019-00531, 3009784280-2019-00532. REPORT SOURCE: FOREIGN- (B)(6)/ STUDY NAME: (B)(6)- PATIENT ID # (B)(6). PMA NUMBER IS NOT APPLICABLE. THE DEVICE IS A NON-COMMERCIAL PRODUCT WITH A CE MARK THAT WAS USED AS PART OF A CLINICAL STUDY. DURING THE INDEX PROCEDURE, THE PRODUCT WORKED AS INTENDED. THE DEVICE WAS DISCARDED, THUS NO PRODUCT EVALUATION WAS PERFORMED. PER THE IFU, RESTENOSIS IS LISTED AS A POTENTIAL COMPLICATIONS/ADVERSE EVENTS.
IT WAS REPORTED THROUGH A CLINICAL STUDY THAT DURING THE INDEX PROCEDURE ON (B)(6) 2017, FOUR STELLAREX CATHETERS WERE USED TO TREAT THE TARGET LESION OF THE RIGHT PROXIMAL, MID, AND DISTAL SFA AND POPLITEAL, P1 AND P3. APPROXIMATELY 11 MONTHS POST INDEX PROCEDURE, THE PATIENT EXPERIENCED RESTENOSIS. A SUCCESSFUL REVASCULARIZATION OF THE TARGET LESION WAS PERFORMED ON (B)(6) 2019. THE PHYSICIAN INDICATED THIS IS NOT RELATED TO THE STUDY DEVICE OR PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 596449 | STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON | DCB PTA CATHETER | ONU | SPECTRANETICS | A35SX050120135 | FFX17D21A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | Hospitalization| R |